The Cell Therapy stream explores the critical challenges facing the manufacture, analysis and quality of cell-based therapies. Topics include product and process characterization, CMC strategies, autologous and allogeneic manufacturing strategies, automation, scale-up and supply of CAR Ts and next-generation cell therapies such as NK cells, TILs, iPSCs and TCR-based therapies.

Conferences Include:

Keynote Presentations:

Innovative CMC Strategies for Cell and Gene Therapies
Zhimei Du, PhD, Vice President, Translational Research and Early Development, LandMark Bio

Manufacturing Gamma Deltas
Kate M. Rochlin, PhD, COO, IN8bio, Inc.

The (Re)emerging Field of Xenotransplantation
Knut Niss, PhD, CTO, eGenesis, Inc.